Daily Research News Online

The global MR industry's daily paper since 2000

M3 Global Research Buys Germany's pharma-insight

May 20 2022

Healthcare specialist M3 Global Research has acquired Germany-based pharma-insight GmbH, which offers a portfolio of MR services to the life sciences industry, including access to a dedicated healthcare panel. Terms of the deal were not disclosed.

Gabi BausFounded in 2003 by the Baus family and headquartered in Hilden, Germany, pharma-insight works with target groups across the life sciences and healthcare industries, offering a full range of qual and quant methods. Services can be used to support product development, the design of communications material, audience segmentation initiatives and channel evaluation.

Following the buy, pharma-insight will continue under the stewardship of co-founder Gabi Baus (pictured) and the team, with Guido Baus taking on the role of a consultant to support the firm's integration into the M3 family. The acquisition follows M3's recent acquisition of Sydney, Australia-based fieldwork firm Ekas.

M3 Global Research's CEO Anton Richter comments: 'The pharma-insight team's wealth of experience and deep knowledge of the healthcare space is a perfect fit with M3's global proposition. This acquisition represents our commitment to continuous investment in our core markets, and we look forward to being able to leverage a dedicated physical presence in Germany for the benefit of our clients'.

Web sites: www.m3global.com and www.pharma-insight.com .

All articles 2006-22 written and edited by Mel Crowther and/or Nick Thomas unless otherwise stated.

Select a region below...
View all recent news
for UK
View all recent news
for USA
View all recent news
for Asia
View all recent news
for Australia


To receive (free) news headlines by email, please register online